Figure 2:
Results of humoral antibody curve throughout the vaccination course and after challenge with VNDV “NDV-CH-EGY-GIZA-VVTNRC-2021” in all experimental groups A, B, C, and D.
Results of humoral antibody curve throughout the vaccination course and after challenge with VNDV “NDV-CH-EGY-GIZA-VVTNRC-2021” in all experimental groups A, B, C, and D.